News Report Exposes “Patient Advocacy” Groups as a Big Pharma Scam
EYE-OPENING NEW REPORT Exposes “Patient Advocacy” Groups as a Big Pharma Scam:
A new report from the Project on Government Oversight reports that at least 39 of 42 patient advocacy groups who recently participated in discussions with the Food and Drug Administration (FDA) over review processes for prescription drugs received funding from pharmaceutical companies. And at least 15 have representatives of drug or biotechnology companies on their governing boards.
The FDA is supposed to be protecting people from potentially harmful drugs and vaccines. But this report shows a serious conflict of interest at agency that is supposed to protect patients NOT protecting pharmaceutical profits!
It’s time to take back our health and do our own research — the FDA review process can no longer be trusted.
In FDA Meetings, “Voice” of the Patient Often Funded by Drug Companies
At an August 15, 2016, public forum convened by the Food and Drug Administration, panelist Marc Boutin introduced himself as CEO of National Health Council and said his organization provides “a united voice for people with chronic disease and disabilities.” Speaking at the agency’s invitation, he proceeded to praise a far-reaching deal the FDA had struck with the pharmaceutical lobby—a bargain designed in part to speed FDA approval of new drugs.
Boutin’s comments added credibility to the deal and wrapped it in the embrace of suffering patients, a group bound to evoke sympathy.
But there were a few things neither Boutin nor his hosts at the FDA mentioned.
National Health Council gets most of its funding from drug companies, its members include many drug companies, and representatives of drug companies and their main lobbying organizations serve on its board.
Read full article: http://www.pogo.org/…/in-fda-meetings-voice-of-the-patient-…